Affiliation:
1. Clinical Chemist, Hospital Ramón y Cajal , Madrid , Spain
2. Rheumatologist, Hospital Ramón y Cajal , Madrid , Spain
Abstract
Abstract
Objectives
We evaluated the prevalence of 25-hydroxyvitamin D (25-(OH)D) deficiency in our setting according to season, sex, and age. We also studied the association with parathyroid hormone (PTH) levels.
Methods
The study population comprised all patients with requests for assessment of 25-(OH)D between January 1 and December 31, 2018, as registered in the database of the laboratory information system. Major exclusion criteria were pediatric samples (<18 years) and factors affecting 25-(OH)D and/or PTH levels (i.e., kidney injury, liver disease, PTH disorders).
Results
Among 33,601 patients (24,028 women, 9,573 men), the prevalence of 25-(OH)D deficiency was 48%. Prevalence was greater in males than in females (53% vs. 46%). By age group, deficiency was more prevalent in quartile 1 (Q1, 74–87 years) and less prevalent in quartile 2 (Q2, 60–73 years). By season, deficiency was greater in spring (nonsignificant differences with respect to winter) and lower in summer. The association between 25-(OH)D and PTH was assessed in 9,368 persons. Linear regression analysis showed a weak association (coefficient – 0.303). Multiple logistic regression analysis revealed a significant association between 25-(OH)D deficiency and increased PTH (Odds ratio (OR), 1.63). Other risk factors for increased PTH include female sex (OR, 1.27), season (winter, OR 1.63, spring OR 1.16), and age (quartile 1, OR, 3).
Conclusions
The prevalence of 25-(OH)D deficiency differed according to sex, age, and season of the year. Furthermore, elevation of PTH is mainly influenced by low 25-(OH)D, female sex, season, and age.
Subject
Medical Laboratory Technology,Education,Medicine (miscellaneous)
Reference42 articles.
1. Crowe, FL, Jolly, K, MacArthur, C, Manaseki-Holland, S, Gittoes, N, Hewison, M, et al.. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015. BMJ Open 2019;9:e028355. https://doi.org/10.1136/bmjopen-2018-028355.
2. Cashman, KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int 2020;106:14–29. https://doi.org/10.1007/s00223-019-00559-4.
3. Sempos, CT, Vesper, HW, Phinney, KW, Thienpont, LM, Coates, PM. Vitamin D Standardization Program (VDSP). Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012;243:32–40. https://doi.org/10.3109/00365513.2012.681935.
4. Institute of Medicine (US). Committee to review dietary reference intakes for vitamin D and calcium. In: Ross, AC, Taylor, CL, Yaktine, AL, Del Valle, HB, editors. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US); 2011. Available from: http://www.ncbi.nlm.nih.gov/books/NBK56070/ [Cited 14 Sep 2020].
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Dietary reference values for vitamin D. EFSA J 2016;14:e04547.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献